Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.
The vacuolar ATPases are ATP-dependent proton pumps whose functions include the acidification of intracellular compartments and the extrusion of protons through the cell cytoplasmic membrane. These pumps play a pivotal role in the regulation of cell pH in normal cells and, to a much greater extent, in tumor cells. In fact, the glucose metabolism in hypoxic conditions by the neoplasms leads to an intercellular pH drift towards acidity. The acid microenvironment is modulated through the over-expression of H+ transporters that are also involved in tumor progression, invasiveness, distant spread and chemoresistance. Several strategies to block/downmodulate the efficiency of these transporters are currently being investigated. Among them, proton pump inhibitors have shown to successfully block the H+ transporters in vitro and in vivo, leading to apoptotic death. Furthermore, their action seems to synergize with conventional chemotherapy protocols, leading to chemosensitization and reversal of chemoresistance. Aim of this article is to critically revise the current knowledge of this cellular machinery and to summarize the therapeutic strategies developed to counter this mechanism.
Spugnini
Enrico P
EP
S.A.F.U. Department, Regina Elena Cancer Institute, Rome, Italy.
Citro
Gennaro
G
Fais
Stefano
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003593:Cytoplasm / Q000378:metabolism; D018450:Disease Progression; D005786:Gene Expression Regulation; D006801:Humans; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D017494:Proton Pumps / Q000378:metabolism; D025262:Vacuolar Proton-Translocating ATPases / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000970:Antineoplastic Agents; D054328:Proton Pump Inhibitors; D017494:Proton Pumps; D025262:Vacuolar Proton-Translocating ATPases
Science. 2003 Feb 28;299(5611):1400-3
12610307
J Natl Cancer Inst. 2004 Nov 17;96(22):1702-13
15547183
Cancer Res. 2007 Jun 1;67(11):5408-17
17545622
Nucleic Acids Res. 2003 Aug 1;31(15):4523-30
12888513
J Biol Chem. 2000 Jul 21;275(29):22075-81
10801866
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3497-504
7909602
Cancer Res. 2007 Nov 15;67(22):10627-30
18006801
J Biol Chem. 1994 May 6;269(18):13224-30
8175752
In Vitro Cell Dev Biol Anim. 2008 Jan-Feb;44(1-2):26-30
18034283
Cancer Lett. 2009 Jul 18;280(1):110-9
19299075
Nat Rev Mol Cell Biol. 2007 Nov;8(11):917-29
17912264
Novartis Found Symp. 2001;240:169-81; discussion 181-5
11727928
Biochem J. 1997 Jun 15;324 ( Pt 3):697-712
9210392
Biochem Pharmacol. 1999 May 1;57(9):1037-46
10796074
Nat Rev Cancer. 2005 Oct;5(10):786-95
16175178
J Biol Chem. 2009 Jun 12;284(24):16400-16408
19366680
Biochem Pharmacol. 1999 Feb 1;57(3):309-12
9890558
Nat Rev Cancer. 2004 Nov;4(11):891-9
15516961
J Biol Chem. 2002 Sep 27;277(39):36534-43
12133827
J Biol Chem. 1988 Jun 25;263(18):8796-802
2897963
J Biol Chem. 1992 Oct 5;267(28):19769-72
1400289
J Exp Ther Oncol. 1996 Jan;1(1):49-61
9414388
Cancer Res. 2004 Sep 1;64(17):6160-5
15342400
Cancer Res. 2005 Aug 1;65(15):6843-9
16061667
Biochem Pharmacol. 2003 Oct 1;66(7):1207-18
14505800
Am J Physiol Cell Physiol. 2004 Jun;286(6):C1443-52
14761893
Cancer Res. 2009 Mar 15;69(6):2260-8
19276390
Science. 2002 Mar 29;295(5564):2387-92
11923519
J Clin Invest. 2008 Dec;118(12):3835-7
19033652
Eur Spine J. 2003 Aug;12(4):341-9
12883962
J Biol Chem. 1992 Mar 15;267(8):5700-11
1544942
Am J Physiol. 1993 Oct;265(4 Pt 1):C1015-29
8238296
J Biol Chem. 1999 Oct 8;274(41):28909-15
10506135
Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1128-32
8302842
Arch Biochem Biophys. 2008 Aug 1;476(1):33-42
18406336
J Biol Chem. 2001 Dec 14;276(50):47411-20
11592965
Nat Rev Mol Cell Biol. 2002 Feb;3(2):94-103
11836511
Int J Cancer. 2010 Jul 1;127(1):207-19
19876915
Neoplasia. 2001 May-Jun;3(3):227-35
11494116
Int J Cancer. 2001 Sep;93(6):869-74
11519050
Cancer Res. 2006 Jul 1;66(13):6699-707
16818644
Br J Cancer. 1999 Jun;80(7):1005-11
10362108
J Biol Chem. 1992 Mar 25;267(9):5817-22
1532573
Cancer Res. 2006 Apr 1;66(7):3629-38
16585188
Cancer Res. 1991 Sep 15;51(18):4955-63
1680024
Clin Exp Metastasis. 1996 Mar;14(2):176-86
8605731
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1147-57
16679513
J Biol Chem. 1999 Jan 15;274(3):1301-5
9880499
Mol Cell Biol. 2005 Jan;25(2):575-89
15632060
Neoplasia. 2003 Nov-Dec;5(6):533-45
14965446
Biochem Pharmacol. 1999 May 1;57(9):1047-58
10796075
Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):599-604
18423392
Br J Cancer. 2003 Sep 1;89(5):877-85
12942121
Mol Pharmacol. 1988 Aug;34(2):180-5
2901030
Biochem Pharmacol. 2003 Oct 1;66(7):1219-29
14505801
J Biol Chem. 2006 Aug 11;281(32):22752-60
16774922
Nat Rev Cancer. 2010 Feb;10(2):147-56
20075923
Drug Discov Today. 2009 Jul;14(13-14):647-60
19443264
Methods Mol Med. 2006;124:347-64
16506429